H.R. 8370In committeeHealth care
FDA would list all dietary supplements in public database
Data as of July 11, 2026
HR 8370 would require supplement makers to register each product with the FDA before it can be legally sold in the U.S.50-second read · 4 questions answered below
Decoded
What does this do?
This bill would require companies that make, package, or distribute dietary supplements to register each product with the FDA. Registration means submitting the product name, ingredients, serving sizes, directions, allergen warnings, and a copy of the label. The FDA would build a public online database so consumers can search this information, though some details like proprietary blend amounts and staff contact info would stay private.
Who does it affect?
This bill directly affects dietary supplement manufacturers, distributors, and retailers. Everyday consumers who buy supplements would also be affected, as they would gain access to a searchable public database of product information.
Why does it matter?
Supplements already on the market when the law takes effect would have 18 months to complete their listings, while new products would need to be listed before going on sale. Any supplement sold without a proper listing on file would be considered mislabeled under federal law, which could expose companies to legal consequences.
Where does it stand?
- Introduced
- House committee — You are here
- House vote
- Senate
- President's desk
Right now: a House committee is reviewing it. If the Senate changes it, it goes back to the House before reaching the President.
AI-drafted summary. Verify it against the official text before you act on it.
Three steps: where you stand, your script, the call.
Make the callSee how a call works
Official title
Dietary Supplement Listing Act of 2026
- Introduced:
- April 20, 2026
- Latest action:
- April 20, 2026
Referred to the House Committee on Energy and Commerce.
Read the official bill on Congress.govMake the call
Three steps: where you stand, your script, the call.